These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 70187)
1. The effect of isoprinosine in subacute sclerosing panencephalitis (SSPE). Streletz LJ; Cracco J Ann Neurol; 1977 Feb; 1(2):183-4. PubMed ID: 70187 [No Abstract] [Full Text] [Related]
2. [Evaluation of the results of treatment of SSPE (subacute sclerosing panencephalitis) with isoprinosine]. Filipowicz A; GrudziĆska B Neurol Neurochir Pol; 1987; 21(4-5):352-6. PubMed ID: 2451185 [TBL] [Abstract][Full Text] [Related]
10. Long-term study of isoprinosine in a case of subacute sclerosing panencephalitis. De Reuck JL; Boon PA; Krahel NL Eur Neurol; 1985; 24(5):294-7. PubMed ID: 2414109 [TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex. Dyken PR; Swift A; DuRant RH Ann Neurol; 1982 Apr; 11(4):359-64. PubMed ID: 6179455 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of subacute sclerosing panencephalitis with methisoprinol. Considerations a propos of 3 cases]. Defanti CA; Mirabile D Riv Neurobiol; 1981; 27(34):621-5. PubMed ID: 6189177 [No Abstract] [Full Text] [Related]
13. The effect of inosiplex on the survival of subacute sclerosing panencephalitis. DuRant RH; Dyken PR Neurology; 1983 Aug; 33(8):1053-5. PubMed ID: 6192362 [TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid IgG changes in subacute sclerosing panencephalitis in the various stages of the disease and during isoprinosine therapy. Poloni M; Rocchelli B; Lanzi G; Rosano Burgio F; Besana D Ital J Neurol Sci; 1981 May; 2(2):177-84. PubMed ID: 6174478 [TBL] [Abstract][Full Text] [Related]